Kanwar JR - Search Results

1

Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells.

Athyala PK, Kanwar JR, Chitipothu S, Kanwar RK, Krishnakumar S, Watson JP, Narayanan J. Athyala PK, et al. Among authors: kanwar rk, kanwar jr. Anticancer Res. 2017 Jul;37(7):3615-3629. doi: 10.21873/anticanres.11732. Anticancer Res. 2017. PMID: 28668853 Free article.

2

Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer.

Athyala PK, Kanwar JR, Alameen M, Kanwar RK, Krishnakumar S, Watson J, Vetrivel U, Narayanan J. Athyala PK, et al. Among authors: kanwar rk, kanwar jr. Biochem Biophys Res Commun. 2016 Jan 8;469(2):257-62. doi: 10.1016/j.bbrc.2015.11.109. Epub 2015 Nov 28. Biochem Biophys Res Commun. 2016. PMID: 26642954

3

Synthesis of saporin-antibody conjugates for targeting EpCAM positive tumour cells.

Athyala PK, Chitipothu S, Kanwar JR, Krishnakumar S, Narayanan J. Athyala PK, et al. Among authors: kanwar jr. IET Nanobiotechnol. 2019 Feb;13(1):90-99. doi: 10.1049/iet-nbt.2018.5222. IET Nanobiotechnol. 2019. PMID: 30964044 Free PMC article.

4

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.

Subramanian N, Kanwar JR, Athalya PK, Janakiraman N, Khetan V, Kanwar RK, Eluchuri S, Krishnakumar S. Subramanian N, et al. Among authors: kanwar rk, kanwar jr. J Biomed Sci. 2015 Jan 9;22:4. doi: 10.1186/s12929-014-0108-9. J Biomed Sci. 2015. PMID: 25576037 Free PMC article.

5

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.

Subramanian N, Kanwar JR, Kanwar RK, Sreemanthula J, Biswas J, Khetan V, Krishnakumar S. Subramanian N, et al. Among authors: kanwar rk, kanwar jr. PLoS One. 2015 Jul 15;10(7):e0132407. doi: 10.1371/journal.pone.0132407. eCollection 2015. PLoS One. 2015. PMID: 26176230 Free PMC article.

6

LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.

Roy K, Kanwar RK, Kanwar JR. Roy K, et al. Among authors: kanwar rk, kanwar jr. Biomaterials. 2015 Dec;71:84-99. doi: 10.1016/j.biomaterials.2015.07.055. Epub 2015 Aug 4. Biomaterials. 2015. PMID: 26318819

7

Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.

Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S. Subramanian N, et al. Among authors: kanwar rk, kanwar jr. Nucleic Acid Ther. 2015 Dec;25(6):317-22. doi: 10.1089/nat.2015.0550. Epub 2015 Sep 3. Nucleic Acid Ther. 2015. PMID: 26334953

8

Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma.

Samuel J, Singh N, Kanwar JR, Krishnakumar S, Kanwar RK. Samuel J, et al. Among authors: kanwar rk, kanwar jr. Exp Eye Res. 2015 Oct;139:108-14. doi: 10.1016/j.exer.2015.07.011. Epub 2015 Jul 23. Exp Eye Res. 2015. PMID: 26213306

9

SurR9C84A protects and recovers human cardiomyocytes from hypoxia induced apoptosis.

Ashok A, Kanwar JR, Krishnan UM, Kanwar RK. Ashok A, et al. Among authors: kanwar rk, kanwar jr. Exp Cell Res. 2017 Jan 1;350(1):19-31. doi: 10.1016/j.yexcr.2016.10.021. Epub 2016 Nov 2. Exp Cell Res. 2017. PMID: 27816606

10

Targeted Theranostics Against Solid Cancer Using Metal Bond Milk Protein and Aptamers.

Chaudhary S, Kanwar RK, Kanwar JR. Chaudhary S, et al. Among authors: kanwar rk, kanwar jr. Curr Top Med Chem. 2017 Jun 7;17(18):2100-2111. doi: 10.2174/1568026617666170130110021. Curr Top Med Chem. 2017. PMID: 28137239 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters